Researchers track Long-Term safety of experimental eye cancer treatment
NCT ID NCT03941379
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study follows people who previously received the experimental drug bel-sar for a type of eye cancer called choroidal melanoma or for suspicious spots on the eye. The goal is to collect information from routine doctor visits to see how safe and effective the treatment is over time. About 63 participants are being monitored for side effects, cancer spread, and overall health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOROIDAL MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Associated Retinal Consultants, PC
Royal Oak, Michigan, 48073, United States
-
Byers Eye Institute at Stanford University
Palo Alto, California, 94303, United States
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, 02114, United States
-
Oregon Health & Science University Casey Eye Institute
Portland, Oregon, 97239, United States
-
Retina Associates SW, P.C.
Tucson, Arizona, 85710, United States
-
Retina Center
Minneapolis, Minnesota, 55404, United States
-
Retina Consultants of Carolina, PA
Greenville, South Carolina, 29605, United States
-
Retina Consultants of Houston
Houston, Texas, 77030, United States
-
Retina Consultants of Sacramento
Sacramento, California, 95825, United States
-
St. Thomas Health / Tennessee Retina, PC
Nashville, Tennessee, 37203, United States
-
Texas Retina Associates
Dallas, Texas, 75231, United States
-
UCLA Jules Stein Eye Institute
Los Angeles, California, 90095, United States
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
-
W. K. Kellogg Eye Center, University of Michigan
Ann Arbor, Michigan, 48105, United States
-
Wills Eye Hospital
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.